Trial Profile
A trial of simeprevir and sofosbuvir combination with or without ribavirin in patients with decompensated cirrosis induced by hepatitis C genotype 1
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Liver cirrhosis
- Focus Adverse reactions; Therapeutic Use
- 09 Sep 2015 New trial record
- 11 Nov 2014 Interim results presented at the 65th Annual Meeting of the American Association for the Study of Liver Diseases.